Home > Financial Ratios > KOPRAN

KOPRAN
Core EBITDA Growth

    Back to All Ratios
KOPRAN is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for KOPRAN
Please provide your vote to see the results

KOPRAN Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 62.27-44.02-1.77110.80-4.18

What is the latest Core EBITDA Growth ratio of KOPRAN ?

The latest Core EBITDA Growth ratio of KOPRAN is 62.27 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202462.27
Mar2023-44.02
Mar2022-1.77
Mar2021110.80
Mar2020-4.18

How is Core EBITDA Growth of KOPRAN Trending?

Years Core EBITDA Growth % Change
Mar2024 62.27
Positive
Mar2023 -44.02
Negative
Mar2022 -1.77
Negative
Mar2021 110.8
Positive
Mar2020 -4.18 -

Other Financial Ratios of KOPRAN


Compare Core EBITDA Growth ratio of peers of KOPRAN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KOPRAN ₹956.8 Cr -3.5% 13.5% -25.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,217.0 Cr 5.7% 3.2% 15.2% Stock Analytics
DIVIS LABORATORIES ₹157,100.0 Cr 2.8% 1.7% 59.1% Stock Analytics
CIPLA ₹123,856.0 Cr 2.5% 2.3% 13.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,850.0 Cr 3.5% 4.4% 27.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,962.2 Cr 2.3% 1.2% -1.4% Stock Analytics


KOPRAN Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KOPRAN

-3.5%

13.5%

-25.1%

SENSEX

4.4%

6.4%

9.8%


You may also like the below Video Courses